1IA
EXAS

1620 Investment Advisors’s Exact Sciences EXAS Stock Holding History

1620 Investment Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5
Closed -$313 – 719
2024
Q3 		$313 Buy
+5
New +$282 ﹤0.01% 690

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

1620 Investment Advisors's EXAS Position: Q4 2024 in Review

1620 Investment Advisors sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 5 shares — an estimated $313 sold.

1620 Investment Advisors first reported a position in EXAS in Q3 2024 and held it in 1 quarter. The position peaked at $313 in Q3 2024. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • 1620 Investment Advisors reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • 1620 Investment Advisors sold 5 Exact Sciences shares in Q4 2024, an estimated $313.
  • 1620 Investment Advisors first reported a position in Exact Sciences in Q3 2024 and held it in 1 quarter.
  • 1620 Investment Advisors's Exact Sciences position peaked at $313 in Q3 2024.
  • 594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on 1620 Investment Advisors's 13F filing for Q4 2024, filed 11 Feb 2025.